NYSE:ABTMedical Equipment
Abbott Laboratories (NYSE:ABT) Reports Q1 Sales And Income Growth With Earnings At US$0.76
Abbott Laboratories (NYSE:ABT) recently reported positive Q1 2025 results, showing increased sales and net income, which may have bolstered its share price by 14% last quarter. The enhanced financial performance, including a rise in diluted EPS, highlighted profitability improvements. This, coupled with ongoing stock buybacks and a longstanding commitment to dividends, likely contributed to investor confidence. Despite broader market concerns such as U.S.-China trade tensions impacting tech...